NEW YORK, NY / ACCESSWIRE / October 20, 2017 / The Dow Jones and S&P 500 rallied late to close in the green Thursday, which was the 30th anniversary of the 1987 Black Monday stock market crash. The Dow Jones Industrial Average touched a low of 23,052.67 before settling to close at 23,163.04 an increase of 0.02 percent, while the S&P 500 Index hit a low of 2,547.92 before settling to close at 2,562.10, an increase of 0.03 percent. The NASDAQ Composite Index dragged behind, falling 0.29 percent to close at 6,605.07, as Alphabet (Google's parent company), Amazon, Facebook, and Netflix all closed lower.

"It is difficult to say whether today's modest pullback is in deference to the 1987 crash or something else," said Jack Ablin, Chief Investment Officer at BMO Private Bank, according to MarketWatch.

"While there is no question that markets are overvalued and we could see some corrections, the path of least resistance for stocks is still to go higher. I will start reducing risk when credit spreads begin to widen and when we see sustained signs of rising inflation," Ablin added.

RDI Initiates Coverage on:

Agenus Inc.
https://rdinvesting.com/news/?ticker=AGEN

Prana Biotechnology Ltd.
https://rdinvesting.com/news/?ticker=PRAN

Agenus Inc.'s stock moved 5.10% lower Thursday, to close the day at $4.47. The stock recorded a trading volume of 4,709,969 shares, which was above its three months average volume of 1,064,550 shares. In the last year, Agenus Inc.'s shares have traded in a range of 3.20 - 5.98. The share price has gained 39.69% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.30 is greater than its 200-day moving average of $3.93. Shares of Agenus have gained approximately 8.5 percent year-to-date.

Access RDI's Agenus Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AGEN

On Thursday, shares of Prana Biotechnology Ltd. recorded a trading volume of 1,061,606 shares, which was above the three months average volume of 20,894 shares. The stock ended the day 24.52% higher at 3.25. The share price has gained 113.82% from its 52-week low with a 52-week trading range of 1.52 - 4.58.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.72 is greater than its 200-day moving average of $2.62. Shares of Prana Biotechnology have gained approximately 99.39 percent year-to-date.

Access RDI's Prana Biotechnology Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=PRAN

Our Actionable Research on Agenus Inc. (NASDAQ: AGEN) and Prana Biotechnology Ltd. (NASDAQ: PRAN) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com